 Gabriela Garcia
Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glomerulonephritis | 3 | 2021 | 47 | 1.300 |
Why?
| | Renal Insufficiency, Chronic | 9 | 2023 | 623 | 0.880 |
Why?
| | Fructokinases | 7 | 2025 | 35 | 0.830 |
Why?
| | Uric Acid | 10 | 2021 | 164 | 0.810 |
Why?
| | Kidney Diseases | 4 | 2023 | 409 | 0.800 |
Why?
| | Fructose | 9 | 2025 | 117 | 0.740 |
Why?
| | Folate Receptor 2 | 1 | 2021 | 9 | 0.710 |
Why?
| | Inflammation | 3 | 2022 | 2902 | 0.550 |
Why?
| | Fibrosis | 2 | 2021 | 542 | 0.530 |
Why?
| | Glomerular Basement Membrane | 2 | 2020 | 9 | 0.510 |
Why?
| | Macrophages | 3 | 2021 | 1562 | 0.490 |
Why?
| | Kidney | 7 | 2023 | 1482 | 0.450 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2015 | 98 | 0.450 |
Why?
| | Hyperuricemia | 3 | 2021 | 45 | 0.440 |
Why?
| | Protein Subunits | 1 | 2015 | 232 | 0.430 |
Why?
| | Dehydration | 4 | 2023 | 54 | 0.350 |
Why?
| | Metabolic Syndrome | 3 | 2023 | 349 | 0.340 |
Why?
| | AMP Deaminase | 3 | 2015 | 11 | 0.320 |
Why?
| | Heat Stress Disorders | 2 | 2023 | 82 | 0.320 |
Why?
| | Podocytes | 2 | 2020 | 68 | 0.300 |
Why?
| | Fatty Liver | 3 | 2018 | 232 | 0.280 |
Why?
| | Heat-Shock Response | 2 | 2018 | 77 | 0.270 |
Why?
| | Liver Diseases, Alcoholic | 1 | 2025 | 94 | 0.220 |
Why?
| | High Fructose Corn Syrup | 1 | 2023 | 8 | 0.200 |
Why?
| | Nephrology | 1 | 2023 | 61 | 0.190 |
Why?
| | Aminopterin | 1 | 2021 | 3 | 0.180 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2021 | 55 | 0.180 |
Why?
| | Renin-Angiotensin System | 1 | 2021 | 77 | 0.170 |
Why?
| | Hot Temperature | 3 | 2019 | 406 | 0.170 |
Why?
| | Animals | 17 | 2025 | 37749 | 0.170 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2021 | 101 | 0.170 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 5909 | 0.170 |
Why?
| | Japan | 5 | 2017 | 133 | 0.160 |
Why?
| | Hypertension | 3 | 2017 | 1254 | 0.160 |
Why?
| | Receptors, Fc | 1 | 2020 | 56 | 0.160 |
Why?
| | Methotrexate | 1 | 2021 | 255 | 0.160 |
Why?
| | Kidney Glomerulus | 2 | 2018 | 121 | 0.160 |
Why?
| | Folic Acid | 1 | 2021 | 198 | 0.160 |
Why?
| | Glomerular Filtration Rate | 3 | 2021 | 752 | 0.160 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2608 | 0.150 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2020 | 209 | 0.150 |
Why?
| | Rats | 4 | 2022 | 5637 | 0.150 |
Why?
| | Alcohol Drinking | 1 | 2025 | 835 | 0.140 |
Why?
| | Kidney Calculi | 1 | 2018 | 36 | 0.140 |
Why?
| | Diabetes Mellitus | 2 | 2017 | 1077 | 0.140 |
Why?
| | B7-1 Antigen | 1 | 2018 | 58 | 0.140 |
Why?
| | Proteinuria | 1 | 2018 | 99 | 0.140 |
Why?
| | Obesity, Metabolically Benign | 1 | 2017 | 4 | 0.140 |
Why?
| | Prehypertension | 1 | 2017 | 27 | 0.140 |
Why?
| | Mice | 10 | 2025 | 18109 | 0.130 |
Why?
| | Fluid Therapy | 1 | 2018 | 142 | 0.130 |
Why?
| | Urinary Calculi | 1 | 2017 | 10 | 0.130 |
Why?
| | Mice, Knockout | 6 | 2025 | 3071 | 0.130 |
Why?
| | Asymptomatic Diseases | 1 | 2017 | 92 | 0.130 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2015 | 199 | 0.120 |
Why?
| | Vasopressins | 1 | 2016 | 60 | 0.120 |
Why?
| | Nanoparticles | 1 | 2022 | 484 | 0.120 |
Why?
| | Liver | 4 | 2025 | 1820 | 0.120 |
Why?
| | Hypothalamus | 1 | 2016 | 155 | 0.120 |
Why?
| | Sodium | 1 | 2017 | 196 | 0.120 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2014 | 199 | 0.120 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 1 | 2015 | 9 | 0.120 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 1 | 2015 | 15 | 0.120 |
Why?
| | Albuminuria | 1 | 2016 | 185 | 0.120 |
Why?
| | Energy Metabolism | 2 | 2019 | 932 | 0.120 |
Why?
| | Dyslipidemias | 1 | 2017 | 175 | 0.110 |
Why?
| | Hepatocytes | 2 | 2012 | 211 | 0.110 |
Why?
| | Fibrin | 1 | 2015 | 91 | 0.110 |
Why?
| | Hibernation | 1 | 2015 | 75 | 0.110 |
Why?
| | Starvation | 1 | 2014 | 23 | 0.110 |
Why?
| | Gluconeogenesis | 1 | 2014 | 78 | 0.100 |
Why?
| | Kidney Tubules, Proximal | 1 | 2014 | 132 | 0.100 |
Why?
| | Adenylate Kinase | 1 | 2012 | 27 | 0.100 |
Why?
| | Mitochondria | 1 | 2019 | 979 | 0.100 |
Why?
| | Collagen | 1 | 2015 | 460 | 0.100 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 498 | 0.090 |
Why?
| | Obesity | 3 | 2023 | 3008 | 0.090 |
Why?
| | Kidney Transplantation | 1 | 2018 | 678 | 0.090 |
Why?
| | Mice, Obese | 2 | 2023 | 67 | 0.090 |
Why?
| | Diabetic Nephropathies | 1 | 2014 | 299 | 0.080 |
Why?
| | Adipose Tissue | 1 | 2015 | 647 | 0.080 |
Why?
| | Cytokines | 2 | 2015 | 2100 | 0.080 |
Why?
| | Male | 13 | 2025 | 70179 | 0.080 |
Why?
| | Risk Factors | 6 | 2018 | 10482 | 0.080 |
Why?
| | Hep G2 Cells | 3 | 2014 | 71 | 0.070 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4421 | 0.070 |
Why?
| | Climate Change | 2 | 2023 | 187 | 0.070 |
Why?
| | Kidney Tubules | 2 | 2019 | 116 | 0.070 |
Why?
| | Kidney Function Tests | 2 | 2019 | 159 | 0.070 |
Why?
| | Humans | 15 | 2023 | 141754 | 0.060 |
Why?
| | Cohort Studies | 4 | 2018 | 5815 | 0.060 |
Why?
| | Aging | 1 | 2016 | 1924 | 0.060 |
Why?
| | Body Mass Index | 3 | 2018 | 2385 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 2096 | 0.060 |
Why?
| | Middle Aged | 7 | 2018 | 34647 | 0.050 |
Why?
| | Dietary Sucrose | 1 | 2023 | 48 | 0.050 |
Why?
| | Retrospective Studies | 5 | 2018 | 16374 | 0.050 |
Why?
| | Logistic Models | 2 | 2017 | 2092 | 0.040 |
Why?
| | Isoenzymes | 2 | 2012 | 302 | 0.040 |
Why?
| | Sex Factors | 2 | 2017 | 2063 | 0.040 |
Why?
| | Silicon Dioxide | 1 | 2022 | 118 | 0.040 |
Why?
| | Ethanol | 1 | 2025 | 629 | 0.040 |
Why?
| | Incidence | 2 | 2017 | 2806 | 0.040 |
Why?
| | Blood Pressure | 2 | 2017 | 1748 | 0.040 |
Why?
| | Adult | 6 | 2018 | 39391 | 0.040 |
Why?
| | Oxidation-Reduction | 2 | 2015 | 1087 | 0.040 |
Why?
| | Female | 6 | 2018 | 75943 | 0.040 |
Why?
| | Calcium Oxalate | 1 | 2018 | 5 | 0.040 |
Why?
| | Nephrosis | 1 | 2018 | 6 | 0.040 |
Why?
| | Galactosyltransferases | 1 | 2018 | 12 | 0.040 |
Why?
| | Nephrosis, Lipoid | 1 | 2018 | 10 | 0.040 |
Why?
| | Abatacept | 1 | 2018 | 56 | 0.040 |
Why?
| | CD40 Ligand | 1 | 2018 | 41 | 0.040 |
Why?
| | Papio | 1 | 2018 | 94 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 82 | 0.030 |
Why?
| | Urinalysis | 1 | 2018 | 77 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 193 | 0.030 |
Why?
| | CTLA-4 Antigen | 1 | 2018 | 103 | 0.030 |
Why?
| | Aged | 4 | 2018 | 24746 | 0.030 |
Why?
| | Animals, Genetically Modified | 1 | 2018 | 242 | 0.030 |
Why?
| | Renal Dialysis | 1 | 2021 | 457 | 0.030 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.030 |
Why?
| | Adenine | 1 | 2019 | 331 | 0.030 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 492 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 2017 | 167 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1197 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 157 | 0.030 |
Why?
| | Age Distribution | 1 | 2017 | 397 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 381 | 0.030 |
Why?
| | Lipocalin-2 | 1 | 2016 | 79 | 0.030 |
Why?
| | Time Factors | 2 | 2017 | 6966 | 0.030 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2016 | 200 | 0.030 |
Why?
| | Swine | 1 | 2018 | 812 | 0.030 |
Why?
| | Water | 1 | 2018 | 466 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 858 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2017 | 7923 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2014 | 26 | 0.030 |
Why?
| | Creatinine | 1 | 2016 | 490 | 0.030 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2014 | 14 | 0.030 |
Why?
| | Glucose-6-Phosphatase | 1 | 2014 | 33 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 855 | 0.030 |
Why?
| | Urate Oxidase | 1 | 2014 | 11 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2014 | 60 | 0.030 |
Why?
| | History, Ancient | 1 | 2014 | 53 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 145 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2014 | 62 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2018 | 900 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2016 | 1321 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2014 | 136 | 0.030 |
Why?
| | Sciuridae | 1 | 2015 | 147 | 0.030 |
Why?
| | Hominidae | 1 | 2014 | 88 | 0.030 |
Why?
| | Chemokines | 1 | 2014 | 228 | 0.020 |
Why?
| | Phosphates | 1 | 2014 | 181 | 0.020 |
Why?
| | Europe | 1 | 2014 | 411 | 0.020 |
Why?
| | Carbon-Carbon Double Bond Isomerases | 1 | 2012 | 2 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2014 | 274 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2020 | 4212 | 0.020 |
Why?
| | Fats | 1 | 2012 | 18 | 0.020 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2012 | 23 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 172 | 0.020 |
Why?
| | Allopurinol | 1 | 2012 | 68 | 0.020 |
Why?
| | Seasons | 1 | 2015 | 546 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 1972 | 0.020 |
Why?
| | Selection, Genetic | 1 | 2014 | 264 | 0.020 |
Why?
| | Comorbidity | 1 | 2017 | 1664 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 450 | 0.020 |
Why?
| | Phosphorylation | 1 | 2016 | 1774 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2075 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 528 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 674 | 0.020 |
Why?
| | Databases, Factual | 1 | 2017 | 1448 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2012 | 811 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 429 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2012 | 378 | 0.020 |
Why?
| | Polymers | 1 | 2014 | 495 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3294 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2800 | 0.020 |
Why?
| | Body Weight | 1 | 2014 | 997 | 0.020 |
Why?
| | Prevalence | 1 | 2017 | 2799 | 0.020 |
Why?
| | Glucose | 1 | 2015 | 1041 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 860 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2017 | 2938 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2012 | 855 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4137 | 0.020 |
Why?
| | Metformin | 1 | 2012 | 333 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2828 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 4080 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3508 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2525 | 0.020 |
Why?
| | Models, Biological | 1 | 2014 | 1828 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2012 | 682 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 4190 | 0.010 |
Why?
| | Insulin Resistance | 1 | 2014 | 1225 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5697 | 0.010 |
Why?
| | Blood Glucose | 1 | 2014 | 2278 | 0.010 |
Why?
| | Insulin | 1 | 2014 | 2491 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 22130 | 0.010 |
Why?
|
|
Garcia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|